Repligen | RGEN - Trade Debtors

Stock Price
116.99
Daily Change
-1.30 -1.10%
Monthly
4.93%
Yearly
-16.09%
Q2 Forecast
115.08

Repligen reported $158.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.52B 34M Dec/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio Techne USD 184.61M 717K Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Bruker USD 544.9M 6M Dec/2025
Charles River Laboratories USD 1.43B 54.59M Dec/2025
Danaher USD 4.76B 845M Mar/2026
Dentsply International USD 688M 34M Dec/2025
General Electric Aerospace USD 22.18B 6.89B Mar/2026
Henry Schein USD 1.65B 92M Dec/2025
Illumina USD 854M 125M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Myriad Genetics USD 115.3M 2.7M Dec/2025
OraSure Technologies USD 22.2M 2.1M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Repligen USD 158.59M 9.62M Dec/2025
Revvity USD 744.67M 64.41M Dec/2025
Standard Biotools USD 13.43M 109K Dec/2025
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Waters USD 828.84M 80.32M Dec/2025
West Pharmaceutical Services USD 685.6M 111.2M Mar/2026